Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Newsom-Davis

Showing results (61-70 of 403) with videos related to

Pageof 41
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|February 6, 2009
Is TRAIL the holy grail of cancer therapy?Thomas Newsom-Davis, Silvia Prieske, Henning Walczak
European Journal of Biochemistry|August 1, 1985
Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding siteP Whiting, A Vincent, J Newsom-Davis
Postgraduate Medical Journal|October 17, 2013
Novel cancer therapies: treatments driven by tumour biologyRamya Ramaswami, Victoria Harding, Thomas Newsom-Davis
Trends in Neurosciences|December 1, 1989
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorderA Vincent, B Lang, J Newsom-Davis
Biochemical Society Transactions|October 1, 1990
alpha-neurotoxin binding to the human nicotinic acetylcholine receptorA Vincent, D Beeson, J Newsom-Davis
Autoimmunity|January 1, 1988
Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myastheniaF Heidenreich, A Vincent, J Newsom-Davis
Annals of Neurology|March 11, 1999
Endocrine function in Lambert-Eaton myasthenic syndromeP Maddison, A Pinto, J Newsom-Davis
Neurology|June 20, 1998
A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study GroupJ Palace, J Newsom-Davis, B Lecky
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1983
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradationS Wilson, A Vincent, J Newsom-Davis
Expert Opinion on Biological Therapy|August 4, 2009
Immunotherapy for HIV-associated non-Hodgkin's lymphomaThomas Newsom-Davis, Eliyaz Ahamed, Mark Bower
Pageof 41

Showing results (61-70 of 403) with videos related to

Sort By:
Pageof 41
Apoptosis : an International Journal on Programmed Cell Death|February 6, 2009
Is TRAIL the holy grail of cancer therapy?Thomas Newsom-Davis, Silvia Prieske, Henning Walczak
European Journal of Biochemistry|August 1, 1985
Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding siteP Whiting, A Vincent, J Newsom-Davis
Postgraduate Medical Journal|October 17, 2013
Novel cancer therapies: treatments driven by tumour biologyRamya Ramaswami, Victoria Harding, Thomas Newsom-Davis
Trends in Neurosciences|December 1, 1989
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorderA Vincent, B Lang, J Newsom-Davis
Biochemical Society Transactions|October 1, 1990
alpha-neurotoxin binding to the human nicotinic acetylcholine receptorA Vincent, D Beeson, J Newsom-Davis
Autoimmunity|January 1, 1988
Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myastheniaF Heidenreich, A Vincent, J Newsom-Davis
Annals of Neurology|March 11, 1999
Endocrine function in Lambert-Eaton myasthenic syndromeP Maddison, A Pinto, J Newsom-Davis
Neurology|June 20, 1998
A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study GroupJ Palace, J Newsom-Davis, B Lecky
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1983
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradationS Wilson, A Vincent, J Newsom-Davis
Expert Opinion on Biological Therapy|August 4, 2009
Immunotherapy for HIV-associated non-Hodgkin's lymphomaThomas Newsom-Davis, Eliyaz Ahamed, Mark Bower
Pageof 41